Clinical trialNCT04684602RecruitingPhase 1/PHASE2Interventional

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

SponsorThomas Advanced Medical LLCEnrollment5,000Autoimmune DiseasesCardiovascular DisordersDiabetes ComplicationsIntegumentary DiseaseMusculoskeletal DisordersNeurodegenerative Disorders+5 more conditions

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Ernst R Von Schwarz, MD, PhD
HeartStem Institute, Southern California Hospital at Culver City
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple Us-Based Sub-Investigator Sites
Culver City, California, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PrimePro™/ PrimeMSK™

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 9 Jul 2020
Primary completion: 9 Jul 2030
Completion: 9 Dec 2030
Last update posted: 29 Apr 2022
Registered enrollment: 5,000
Registry id: NCT04684602

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.